David Venzon
Impact in
- Virology top 0.05%
- HIV Research and Treatment
- Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 123
- Immune Cell Function and Interaction 64
- Immunotherapy and Immune Responses 35
- T-cell and B-cell Immunology 32
- Oncology 105
- Co-authors
- Suresh H. Moolgavkar (12 shared papers)Robert T. Jensen (29 shared papers)Fathia Gibril (24 shared papers)H. Richard Alexander (17 shared papers)Marjorie Robert-Guroff (51 shared papers)Jeffrey A. Norton (13 shared papers)Douglas L. Fraker (12 shared papers)John L. Doppman (8 shared papers)
- Journals
- Journal of Virology (28 papers)The Journal of Urology (19 papers)The Journal of Immunology (15 papers)Journal of Clinical Oncology (15 papers)The Journal of Infectious Diseases (14 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
David Venzon
399 papers receiving 20.6k citations
Peers
Comparison fields: 5 of 182
- Virology 4.4k
- Immunology 5.7k
- Oncology 5.8k
- Epidemiology 6.2k
- Neurology 2.4k
Countries citing papers authored by David Venzon
This map shows the geographic impact of David Venzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Venzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Venzon more than expected).
Fields of papers citing papers by David Venzon
This network shows the impact of papers produced by David Venzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Venzon. The network helps show where David Venzon may publish in the future.
Co-authors
The 25 scholars most cited alongside David Venzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 420 | |
| 2 | 1993 | 414 | |
| 3 | 2008 | 375 | |
| 4 | 1979 | 371 | |
| 5 | 1999 | 330 | |
| 6 | 1996 | 330 | |
| 7 | Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. | 1996 | 321 |
| 8 | 1991 | 246 | |
| 9 | 1999 | 241 | |
| 10 | 2000 | 228 | |
| 11 | 2005 | 227 | |
| 12 | 1997 | 225 | |
| 13 | 1998 | 201 | |
| 14 | Tempol, a stable free radical, is a novel murine radiation protector. | 1992 | 197 |
| 15 | 2001 | 194 | |
| 16 | 2008 | 186 | |
| 17 | 1999 | 179 | |
| 18 | 2002 | 179 | |
| 19 | 1988 | 175 | |
| 20 | 1991 | 174 |
About David Venzon
David Venzon is a scholar working on Immunology, Oncology, Virology, Epidemiology and Molecular Biology, having authored 402 papers that have together received 21.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (101 papers), Immune Cell Function and Interaction (64 papers), Neuroendocrine Tumor Research Advances (40 papers), Immunotherapy and Immune Responses (35 papers), T-cell and B-cell Immunology (32 papers), Neuroblastoma Research and Treatments (25 papers), HIV/AIDS drug development and treatment (24 papers) and Virus-based gene therapy research (23 papers). The work is most often cited by research in Virology (4.4k citations), Immunology (5.7k citations), Oncology (5.8k citations), Epidemiology (6.2k citations) and Neurology (2.4k citations). David Venzon has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Suresh H. Moolgavkar, Robert T. Jensen, Fathia Gibril, H. Richard Alexander, Marjorie Robert-Guroff, Jeffrey A. Norton, Douglas L. Fraker, John L. Doppman, McClellan M. Walther and William D. Figg. Their work appears in journals such as Journal of Virology, The Journal of Urology, The Journal of Immunology, Journal of Clinical Oncology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.